In agreement, LSD1 inhibition in SSc cells had no effect on ACTA2, CTGF, or HES1 transcript levels (Figure 3G–I), although it significantly reduced COL1A2 expression (Figure 3F). Here, HES1 is linked to systemic sclerosis.